MedPath

Influence of time of vaccination on Hepatitis B vaccine responses in health care students

Phase 1
Conditions
The immune response to Hepatitis B vaccine is being investigated.
MedDRA version: 20.1 Level: PT Classification code 10019732 Term: Hepatitis B antibody System Organ Class: 10022891 - Investigations
MedDRA version: 20.0 Level: PT Classification code 10054130 Term: Hepatitis B immunisation System Organ Class: 10042613 - Surgical and medical procedures
Therapeutic area: Body processes [G] - Immune system processes [G12]
Registration Number
EUCTR2014-003756-32-GB
Lead Sponsor
Central Manchester University Hospitals NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Age more than or equal to16 years.

University student in good health who consents to fill diary cards, provide saliva and blood samples and is able to attend a morning/afternoon/evening vaccination session

Are the trial subjects under 18? yes
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range 0

Exclusion Criteria

- History of HepB infection or vaccination
- Immunosuppression including HIV or chronic/current steroid use
- Receipt of blood products or IgG within 3 months of enrolment
- Any contraindication to Hepatitis B vaccination per Green Book

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath